Achievement of Early Deep Remission Is Associated with Lower Rates of Weekly Dosing for Adalimumab-Treated Patients with Crohn's Disease: Data from EXTEND

被引：3

作者：

Sandborn, William ^{[1
]}

Colombel, Jean-Frederic ^{[2
]}

Lomax, Kathleen ^{[3
]}

Pollack, Paul ^{[3
]}

Thakkar, Roopal ^{[3
]}

Camez, Anne ^{[4
]}

Chen, Naijun ^{[3
]}

Yang, Mei ^{[3
]}

Chao, Jingdong ^{[3
]}

Mulani, Parvez ^{[3
]}

机构：

[1] Mayo Clin, Rochester, MN USA

[2] CHU Lille, F-59037 Lille, France

[3] Abbott Labs, Abbott Pk, IL 60064 USA

[4] Abbott GmbH & Co KG, Ludwigshafen, Germany

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2010年 / 105卷

关键词：

D O I：

10.14309/00000434-201010001-01208

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1208

引用

页码：S442 / S443

页数：2

共 50 条

[1] ACHIEVEMENT OF EARLY DEEP REMISSION IS ASSOCIATED WITH LOWER RATES OF WEEKLY DOSING FOR ADALIMUMAB-TREATED PATIENTS WITH CROHN'S DISEASE: DATA FROM EXTEND
Sandborn, W. J.
Colombel, J. F.
Lomax, K. G.
Pollack, P. F.
Thakkar, R.
Camez, A.
Chen, N.
Yang, M.
Chao, J.
Mulani, P. M.
GUT, 2011, 60
[2] Achievement of early deep remission is associated with lower rates of weekly dosing for adalimumab-treated patients with Crohn's disease: Data from EXTEND.
Sandborn, W.
Colombel, J.
Lomax, K.
Pollack, P.
Thakkar, R.
Camez, A.
Chen, N.
Yang, M.
Chao, J.
Mulani, P.
INFLAMMATORY BOWEL DISEASES, 2011, 17 : S61 - S61
[3] Achievement of Early Deep Remission Predicts Better Long-Term Outcomes for Adalimumab-Treated Patients with Crohn's Disease: Data from EXTEND
Colombel, Jean-Frederic
Rutgeerts, Paul
Sandborn, William
Yang, Mei
Lomax, Kathleen
Pollack, Paul
Thakkar, Roopal
Camez, Anne
Chen, Naijun
Chao, Jingdong
Mulani, Parvez
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S434 - S435
[4] Economic Impact of Deep Remission in Adalimumab-Treated Patients With Crohn's Disease: Results From Extend
Sandborn, William J.
Colombel, Jean-Frederic
Louis, Edouard
Panaccione, Remo
Yang, Mei
Chao, Jingdong
Mulani, Parvez
GASTROENTEROLOGY, 2011, 140 (05) : S205 - S205
[5] Achievement of early deep remission predicts better long-term outcomes for adalimumab-treated patients with Crohn's disease: Data from EXTEND.
Sandborn, W.
Colombel, J.
Rutgeerts, P.
Yang, M.
Lomax, K.
Pollack, P.
Thakkar, R.
Camez, A.
Chen, N.
Chao, J.
Mulani, P.
INFLAMMATORY BOWEL DISEASES, 2011, 17 : S60 - S60
[6] Identification of Subgroups of Adalimumab-Treated Patients With Crohn's Disease Who Experience High Rates of Deep Remission
Sandborn, William J.
Colombel, Jean-Frederic
Louis, Edouard
Panaccione, Remo
Yang, Mei
Chao, Jingdong
Mulani, Parvez
GASTROENTEROLOGY, 2011, 140 (05) : S214 - S214
[7] Subanalysis of Remission Rates By Duration of Disease in Adalimumab-Treated Patients with Crohn's Disease: the Care Trial
Reinisch, Walter
Lofberg, Robert
Louis, Edouard
Kron, Martina
Camez, Anne
Robinson, Anne
Pollack, Paul F.
GASTROENTEROLOGY, 2009, 136 (05) : A523 - A524
[8] Crohn's Disease Mucosal Healing in Adalimumab-Treated Patients is Affected by Disease Duration: Results From Extend
Sandborn, William J.
Panaccione, Remo
Thakkar, Roopal
Lomax, Kathleen G.
Chen, Naijun
Chao, Jingdong
Mulani, Parvez
Yang, Mei
GASTROENTEROLOGY, 2010, 138 (05) : S164 - S164
[9] Growth improvement in adalimumab-treated paediatric patients with Crohn's disease: data from IMAgINE 1
Walters, T.
Faubion, W. A.
Griffiths, A.
Baldassano, R.
Escher, J.
Ruemmele, F.
Hyams, J. S.
Lazar, A.
Eichner, S.
Li, Y.
Pappalardo, B.
Thakkar, R. B.
JOURNAL OF CROHNS & COLITIS, 2014, 8 : S420 - S421
[10] Work Productivity Improvements in Adalimumab-treated Patients with Moderate to Severe Ileocolonic Crohn's Disease: The EXTEND Trial
Binion, David
Rutgeerts, Paul
van Assche, Gert
Chen, Naijun
Chao, Jingdong
Mulani, Parvez
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S462 - S462

← 1 2 3 4 5 →